CONMED Corporation (CNMD) is a publicly traded Healthcare sector company. As of September 10, 2026, CNMD trades at $46.95 with a market cap of $1.40B and a P/E ratio of 25.41. CNMD moved +0.73% today. Year to date, CNMD is +15.59%; over the trailing twelve months it is -13.06%. Its 52-week range spans $31.44 to $74.70. Analyst consensus is neutral with an average price target of $45.25. Rallies surfaces CNMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CONMED Corporation (CNMD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CNMD moved +0.73% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $46.95 |
| Market Cap | $1.40B |
| P/E Ratio | 25.41 |
| EPS | $1.85 |
| Dividend Yield | 0.20% |
| 52-Week High | $74.70 |
| 52-Week Low | $31.44 |
| Volume | 194.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.37B |
| Net Income | $56.50M |
| Gross Margin | 55.79% |
6 analysts cover CNMD: 0 strong buy, 0 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $45.25.